SCHEDULE: Goldman Sachs Reports 0% Stake in Chimerix
Beneficial Ownership Amendment
Goldman Sachs Group and its subsidiary Goldman Sachs & Co. LLC have filed an amended Schedule 13G, indicating they no longer hold beneficial ownership in Chimerix, Inc.
Summary
- The Goldman Sachs Group, Inc. and its subsidiary, Goldman Sachs & Co. LLC, have filed an Amendment No. 1 to their Schedule 13G.
- The filing reports that neither entity beneficially owns any shares of Chimerix, Inc. Common Stock.
- Their aggregate beneficial ownership is 0.00 shares, representing 0.0% of the class.
- This statement is a routine compliance update, certifying that any securities were acquired and held in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer.
Sentiment
Score: 5
Explanation: Neutral. This is a routine compliance filing indicating a major institutional investor no longer holds a reportable stake, which is neither inherently positive nor negative for the issuer's operations or prospects.
Future Outlook
NA
Management Comments
- I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §§ 240.14a-11.
Industry Context
This filing is a routine disclosure of institutional ownership changes and does not provide insights into Chimerix's industry trends or competitive landscape. It merely indicates a major financial institution's current lack of a reportable stake.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Attorney-in-fact (The Goldman Sachs Group, Inc.) | Papa Lette, Akash Keshari, Regina Chan, Andrzej Szyszka, Ameen Soetan, Rahail Patel, Santosh Vinayagamoorthy, Sadhiya Raffique, Matthew Pomfret, Abhishek Vishwanathan, Mariana Audeves, Veronica Mupazviriwo, Elizabeth Novak, Sam Prashanth (from July 29, 2024 POA) | Sadhiya Raffique, Santosh Vinayagamoorthy, D Guru Prasad, Tobi Amusan, Akash Keshari, Papa Lette, Andrzej Szyszka, Rahail Patel, Taiki Misu, Regina Chan, Mariana Audeves Martinez, Asheesh Bajaj, Abhilasha Bareja, Veronica Mupazviriwo, Sam Prashanth, Ameen Soetan, Abhishek Vishwanathan, Elizabeth Novak, Matthew Pomfret | 2025-07-16 | Superseded previous Power of Attorney. |
| Attorney-in-fact (Goldman Sachs & Co. LLC) | Papa Lette, Akash Keshari, Regina Chan, Andrzej Szyszka, Ameen Soetan, Rahail Patel, Santosh Vinayagamoorthy, Sadhiya Raffique, Matthew Pomfret, Abhishek Vishwanathan, Mariana Audeves Martinez, Veronica Mupazviriwo, Elizabeth Novak, Sam Prashanth (from October 1, 2024 POA) | Sadhiya Raffique, Santosh Vinayagamoorthy, D Guru Prasad, Tobi Amusan, Akash Keshari, Papa Lette, Andrzej Szyszka, Rahail Patel, Taiki Misu, Regina Chan, Mariana Audeves Martinez, Asheesh Bajaj, Abhilasha Bareja, Veronica Mupazviriwo, Sam Prashanth, Ameen Soetan, Abhishek Vishwanathan, Elizabeth Novak, Matthew Pomfret | 2025-07-16 | Superseded previous Power of Attorney. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney Update | The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC updated their Power of Attorney, appointing a new list of individuals as attorneys-in-fact for SEC filings. This new POA supersedes previous versions from July 29, 2024, and October 1, 2024. | 2025-07-16 | This is an internal administrative update for Goldman Sachs' compliance procedures, ensuring authorized individuals can sign SEC filings. It has no direct impact on Chimerix, Inc.'s corporate governance. |
Stakeholder Impact
- Shareholders: Minimal direct impact. The filing indicates a major institutional investor no longer holds a reportable stake, which is a factual disclosure of ownership status and does not inherently signal a change in Chimerix's operational or financial fundamentals.
Key Dates
| Date | Description |
|---|---|
| 2024-07-29 | Date of superseded Power of Attorney for The Goldman Sachs Group, Inc. |
| 2024-10-01 | Date of superseded Power of Attorney for Goldman Sachs & Co. LLC. |
| 2025-06-30 | Date of event which requires filing of this statement (reporting period end for beneficial ownership). |
| 2025-07-16 | Date of new Power of Attorney for The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC. |
| 2025-07-17 | Date of signing for the Schedule 13G Amendment No. 1 and Joint Filing Agreement. |
| 2026-07-16 | Expiration date of the current Power of Attorney. |
Keywords
Chimerix Inc., Goldman Sachs, Schedule 13G, Beneficial Ownership, Common Stock, SEC Filing, Institutional Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.